Clinical Trials Browser

Phase 2 × OTHER × Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation × Clear all

NCT05815186 2024-03-29

Ladarixin With Sotorasib in Advanced NSCLC - Phase II

Phase 2 Withdrawn

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation